Article ID Journal Published Year Pages File Type
11029322 Lung Cancer 2018 22 Pages PDF
Abstract
ICIs should be used with caution when treating lung cancer patients who have underlying chronic lung disease, especially interstitial lung disease.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer
Authors
, , , , , , , , , , ,